{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "58468-0220",
      "generic_name": "eliglustat",
      "labeler_name": "Genzyme Corporation",
      "brand_name": "Cerdelga",
      "active_ingredients": [
        {
          "name": "ELIGLUSTAT",
          "strength": "84 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "58468-0220-1",
          "description": "4 BLISTER PACK in 1 CARTON (58468-0220-1)  / 14 CAPSULE in 1 BLISTER PACK",
          "marketing_start_date": "20140903",
          "sample": false
        },
        {
          "package_ndc": "58468-0220-2",
          "description": "1 BLISTER PACK in 1 CARTON (58468-0220-2)  / 14 CAPSULE in 1 BLISTER PACK",
          "marketing_start_date": "20140903",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Genzyme Corporation"
        ],
        "rxcui": [
          "1547225",
          "1547231"
        ],
        "spl_set_id": [
          "819f828a-b888-4e46-83fc-94d774a28a83"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175783",
          "N0000020019",
          "N0000185503",
          "N0000182137"
        ],
        "pharm_class_epc": [
          "Glucosylceramide Synthase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Glucosylceramide Synthase Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Cytochrome P450 2D6 Inhibitors [MoA]"
        ],
        "unii": [
          "DR40J4WA67"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "CAPSULE",
      "spl_id": "e71b0b39-5a29-4e38-8500-55b6d1f48543",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20140903",
      "product_id": "58468-0220_e71b0b39-5a29-4e38-8500-55b6d1f48543",
      "application_number": "NDA205494",
      "brand_name_base": "Cerdelga",
      "pharm_class": [
        "Cytochrome P450 2D6 Inhibitors [MoA]",
        "Glucosylceramide Synthase Inhibitor [EPC]",
        "Glucosylceramide Synthase Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]"
      ]
    }
  ]
}